DrugPatentWatch Database Preview
Profile for United States of America Patent: 8404716
US Patent Family Members and Approved Drugs for United States of America Patent: 8404716
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Apr 11, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Try a Free Trial | Apr 11, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Try a Free Trial | Apr 11, 2023 | Celgene | REVLIMID | lenalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |